PRESS RELEASE
Gothenburg, Sweden December 5th, 2018, 08:30 CET

CELLINK and Prellis Biologics Inc. sign partnership to commercialize high-resolution holographic bioprinting technology for micro-printing.

The partners will utilize their IP, expertise, and know-how to offer the first system enabling ultra-high resolution bioprinting of microstructures such as vascular networks or capillaries. The technology is an important complement to CELLINK’s extrusion based bioprinting platform, enabling combined prints from the two printing technologies for anatomically relevant results.

Prellis Biologics has developed a proprietary ultra-fast, multi-photon laser-based bioprinting technology. Live-cell imaging methods inspired the creation of a tissue printing system designed to replicate real human tissue structures, at never-before seen resolutions. Resolutions that match the microvascular structures of human tissues and extracellular matrix have yet to be seen with any other bioprinting technology. CELLINK as the commercialization partner is responsible for design of the system, user interface development, and sales of the system, ink and consumables to researchers and end-users in the pharmaceutical and academic field.

Read the full press release below

For further information, please contact:

Erik Gatenholm, CEO Phone: +46 73 267 00 00 E-mail: eg@cellink.com
Gusten Danielsson, CFO Phone: +46 70 991 86 04 E-mail: gd@cellink.com